Publication | Closed Access

Alemtuzumab induces enhanced apoptosis in vitro in B-cells from patients with chronic lymphocytic leukemia by antibody-dependent cellular cytotoxicity

Hematological MalignancyLymphoid NeoplasiaChronic Lymphocytic LeukemiaAlemtuzumab InducesApoptosisImmunologyMalignant Blood DisorderCell DeathImmune Checkpoint InhibitorAutoimmunityImmunotherapyMedicineRadiation OncologyAntibody-dependent Cellular CytotoxicityTumor Microenvironment